Hogy Medical Co.,Ltd. (TYO:3593)
4,835.00
+40.00 (0.83%)
Mar 10, 2025, 3:30 PM JST
Hogy Medical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Net Income | 4,290 | 4,075 | 6,189 | 6,286 | 6,989 | 7,725 | Upgrade
|
Depreciation & Amortization | 5,888 | 6,607 | 3,617 | 4,115 | 4,549 | 5,283 | Upgrade
|
Loss (Gain) From Sale of Assets | 739 | 169 | 464 | - | 27 | 4 | Upgrade
|
Loss (Gain) From Sale of Investments | -1,097 | - | - | - | -1,028 | -1,942 | Upgrade
|
Other Operating Activities | -699 | -2,269 | -1,983 | -2,090 | -2,027 | -2,589 | Upgrade
|
Change in Accounts Receivable | -13 | -739 | -504 | 160 | -79 | 641 | Upgrade
|
Change in Inventory | 565 | -410 | 314 | 212 | -1,050 | 399 | Upgrade
|
Change in Accounts Payable | -455 | -602 | 802 | -337 | -408 | 631 | Upgrade
|
Change in Other Net Operating Assets | 2,220 | 286 | 277 | 155 | -119 | 143 | Upgrade
|
Operating Cash Flow | 11,438 | 7,117 | 9,176 | 8,501 | 6,854 | 10,295 | Upgrade
|
Operating Cash Flow Growth | 45.24% | -22.44% | 7.94% | 24.03% | -33.42% | 38.26% | Upgrade
|
Capital Expenditures | -3,655 | -2,686 | -1,318 | -3,048 | -7,350 | -9,767 | Upgrade
|
Sale of Property, Plant & Equipment | 3 | 43 | - | 2 | 3 | 1 | Upgrade
|
Sale (Purchase) of Intangibles | -65 | -115 | -74 | -153 | -190 | -377 | Upgrade
|
Investment in Securities | 664 | -491 | -478 | -830 | 546 | 907 | Upgrade
|
Other Investing Activities | 571 | 37 | -81 | 217 | 41 | 42 | Upgrade
|
Investing Cash Flow | -2,532 | -3,262 | -1,951 | -3,812 | -6,950 | -9,194 | Upgrade
|
Long-Term Debt Issued | - | - | - | 10,000 | - | - | Upgrade
|
Long-Term Debt Repaid | - | -1,999 | -1,999 | -398 | -110 | -110 | Upgrade
|
Net Debt Issued (Repaid) | 8,001 | -1,999 | -1,999 | 9,602 | -110 | -110 | Upgrade
|
Issuance of Common Stock | - | - | - | 117 | 108 | 106 | Upgrade
|
Repurchase of Common Stock | -11,622 | - | - | -18,773 | -453 | -1 | Upgrade
|
Dividends Paid | -1,886 | -1,892 | -1,697 | -1,995 | -2,044 | -1,984 | Upgrade
|
Other Financing Activities | -3 | -1 | 554 | - | -1 | - | Upgrade
|
Financing Cash Flow | -5,510 | -3,892 | -3,142 | -11,049 | -2,500 | -1,989 | Upgrade
|
Foreign Exchange Rate Adjustments | -259 | 310 | 448 | 269 | -150 | 63 | Upgrade
|
Miscellaneous Cash Flow Adjustments | -1 | -1 | - | - | - | 580 | Upgrade
|
Net Cash Flow | 3,136 | 272 | 4,531 | -6,091 | -2,746 | -245 | Upgrade
|
Free Cash Flow | 7,783 | 4,431 | 7,858 | 5,453 | -496 | 528 | Upgrade
|
Free Cash Flow Growth | 30.48% | -43.61% | 44.10% | - | - | -91.04% | Upgrade
|
Free Cash Flow Margin | 19.77% | 11.33% | 20.16% | 14.83% | -1.36% | 1.42% | Upgrade
|
Free Cash Flow Per Share | 337.73 | 182.59 | 323.95 | 190.91 | -16.41 | 17.48 | Upgrade
|
Cash Interest Paid | 49 | 23 | 29 | 6 | 2 | 1 | Upgrade
|
Cash Income Tax Paid | 717 | 2,252 | 1,958 | 2,089 | 2,025 | 2,590 | Upgrade
|
Levered Free Cash Flow | 7,072 | 2,394 | 6,752 | 4,344 | -2,921 | 1,329 | Upgrade
|
Unlevered Free Cash Flow | 7,102 | 2,409 | 6,770 | 4,348 | -2,919 | 1,330 | Upgrade
|
Change in Net Working Capital | -2,480 | 4,003 | -398 | 401 | 3,449 | -2,873 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.